KESON-BROOKES MAIKEN (See Remarks) received a stock award from MURAL ONCOLOGY PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2024ACC: 0000950170-24-024913
Officer· See Remarks
Since Nov 2023
+48K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
48K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+16.80K
Price / share
—
Trade value
—
% of position
57.5%
3/1/2024
29.21K→46.01K
Total
Net shares
+16.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/1/2024 | A · Award | +16.80K | — | — | 57.5% | 29.21K | 46.01K |
| Total | +16.80K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Ordinary Shares
31.20K shares
Shares
+31.20K
Strike price
5.39
Held after
31.20K
Exercisable
—
3/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Ordinary Shares31.20K shares | 3/1/2024 | A · Award | +31.20K | 5.39 | — | 31.20K |